Geode Capital Management’s Integra LifeSciences IART Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $32.2M | Buy |
1,791,635
+134,650
| +8% | +$1.88M | ﹤0.01% | 1882 |
|
|
2026
Q1 | $15.6M | Sell |
1,656,985
-26,979
| -2% | -$296K | ﹤0.01% | 2135 |
|
|
2025
Q4 | $20.9M | Buy |
1,683,964
+135,743
| +9% | +$1.8M | ﹤0.01% | 1982 |
|
|
2025
Q3 | $22.2M | Sell |
1,548,221
-94,331
| -6% | -$1.29M | ﹤0.01% | 1946 |
|
|
2025
Q2 | $20.2M | Sell |
1,642,552
-20,749
| -1% | -$301K | ﹤0.01% | 1954 |
|
|
2025
Q1 | $36.6M | Buy |
1,663,301
+86,643
| +5% | +$2.04M | ﹤0.01% | 1560 |
|
|
2024
Q4 | $35.8M | Sell |
1,576,658
-247,336
| -14% | -$5.4M | ﹤0.01% | 1644 |
|
|
2024
Q3 | $33.1M | Sell |
1,823,994
-3,854
| -0.2% | -$89.3K | ﹤0.01% | 1694 |
|
|
2024
Q2 | $53.3M | Buy |
1,827,848
+507,380
| +38% | +$15M | ﹤0.01% | 1318 |
|
|
2024
Q1 | $46.8M | Buy |
1,320,468
+64,360
| +5% | +$2.57M | ﹤0.01% | 1404 |
|
|
2023
Q4 | $54.7M | Sell |
1,256,108
-6,080
| -0.5% | -$239K | 0.01% | 1287 |
|
|
2023
Q3 | $48.2M | Buy |
1,262,188
+137,942
| +12% | +$5.8M | 0.01% | 1254 |
|
|
2023
Q2 | $46.2M | Buy |
1,124,246
+24,637
| +2% | +$1.19M | 0.01% | 1309 |
|
|
2023
Q1 | $63.1M | Buy |
1,099,609
+37,020
| +3% | +$2.09M | 0.01% | 1015 |
|
|
2022
Q4 | $59.6M | Buy |
1,062,589
+54,238
| +5% | +$2.76M | 0.01% | 1034 |
|
|
2022
Q3 | $42.7M | Buy |
1,008,351
+12,086
| +1% | +$619K | 0.01% | 1190 |
|
|
2022
Q2 | $53.8M | Sell |
996,265
-17,613
| -2% | -$1.06M | 0.01% | 1058 |
|
|
2022
Q1 | $65.2M | Buy |
1,013,878
+7,431
| +0.7% | +$489K | 0.01% | 1063 |
|
|
2021
Q4 | $67.4M | Buy |
1,006,447
+57,231
| +6% | +$3.87M | 0.01% | 1080 |
|
|
2021
Q3 | $65M | Buy |
949,216
+5,609
| +0.6% | +$396K | 0.01% | 1054 |
|
|
2021
Q2 | $64.4M | Buy |
943,607
+18,937
| +2% | +$1.34M | 0.01% | 1096 |
|
|
2021
Q1 | $63.9M | Buy |
924,670
+22,369
| +2% | +$1.52M | 0.01% | 1034 |
|
|
2020
Q4 | $58.6M | Buy |
902,301
+47,555
| +6% | +$2.56M | 0.01% | 994 |
|
|
2020
Q3 | $40.4M | Sell |
854,746
-34,498
| -4% | -$1.64M | 0.01% | 1032 |
|
|
2020
Q2 | $41.8M | Buy |
889,244
+8,038
| +0.9% | +$395K | 0.01% | 992 |
|
|
2020
Q1 | $39.4M | Buy |
881,206
+35,667
| +4% | +$1.87M | 0.01% | 888 |
|
|
2019
Q4 | $49.3M | Buy |
845,539
+13,464
| +2% | +$802K | 0.01% | 942 |
|
|
2019
Q3 | $50M | Buy |
832,075
+4,033
| +0.5% | +$240K | 0.01% | 883 |
|
|
2019
Q2 | $46.2M | Buy |
828,042
+57,910
| +8% | +$2.98M | 0.01% | 911 |
|
|
2019
Q1 | $42.9M | Buy |
770,132
+38,701
| +5% | +$1.97M | 0.01% | 921 |
|
|
2018
Q4 | $33M | Buy |
731,431
+39,637
| +6% | +$2.17M | 0.01% | 955 |
|
|
2018
Q3 | $45.6M | Buy |
691,794
+23,155
| +3% | +$1.44M | 0.01% | 853 |
|
|
2018
Q2 | $43.1M | Buy |
668,639
+75,589
| +13% | +$4.68M | 0.01% | 851 |
|
|
2018
Q1 | $32.8M | Buy |
593,050
+29,653
| +5% | +$1.55M | 0.01% | 948 |
|
|
2017
Q4 | $27M | Buy |
563,397
+2,579
| +0.5% | +$126K | 0.01% | 1055 |
|
|
2017
Q3 | $28.3M | Buy |
560,818
+28,262
| +5% | +$1.45M | 0.01% | 994 |
|
|
2017
Q2 | $29M | Buy |
532,556
+824
| +0.2% | +$39.3K | 0.01% | 942 |
|
|
2017
Q1 | $22.4M | Buy |
531,732
+33,742
| +7% | +$1.44M | 0.01% | 1055 |
|
|
2016
Q4 | $21.4M | Buy |
497,990
+55,166
| +12% | +$2.24M | 0.01% | 1041 |
|
|
2016
Q3 | $18.3M | Buy |
442,824
+32,250
| +8% | +$1.35M | 0.01% | 1062 |
|
|
2016
Q2 | $16.4M | Buy |
410,574
+4,278
| +1% | +$154K | 0.01% | 1079 |
|
|
2016
Q1 | $13.7M | Buy |
406,296
+14,540
| +4% | +$453K | 0.01% | 1157 |
|
|
2015
Q4 | $13.3M | Buy |
391,756
+34,608
| +10% | +$1.08M | 0.01% | 1160 |
|
|
2015
Q3 | $10.6M | Sell |
357,148
-37,947
| -10% | -$1.19M | 0.01% | 1302 |
|
|
2015
Q2 | $10.9M | Buy |
395,095
+10,857
| +3% | +$289K | 0.01% | 1354 |
|
|
2015
Q1 | $9.68M | Buy |
384,238
+19,322
| +5% | +$457K | 0.01% | 1408 |
|
|
2014
Q4 | $8.09M | Buy |
364,916
+32,722
| +10% | +$663K | ﹤0.01% | 1498 |
|
|
2014
Q3 | $6.74M | Buy |
332,194
+1,842
| +0.6% | +$36.7K | ﹤0.01% | 1569 |
|
|
2014
Q2 | $6.35M | Buy |
330,352
+25,473
| +8% | +$475K | ﹤0.01% | 1638 |
|
|
2014
Q1 | $5.73M | Buy |
304,879
+10,324
| +4% | +$199K | ﹤0.01% | 1675 |
|
|
2013
Q4 | $5.74M | Buy |
294,555
+30,246
| +11% | +$555K | ﹤0.01% | 1595 |
|
|
2013
Q3 | $4.35M | Buy |
264,309
+2,681
| +1% | +$43K | ﹤0.01% | 1659 |
|
|
2013
Q2 | $3.92M | Buy |
+261,628
| New | +$3.83M | ﹤0.01% | 1594 |
|
Other funds holding IART
RCMNY
PCMI
Geode Capital Management's IART Position: Q2 2026 in Review
Geode Capital Management increased its Integra LifeSciences (IART) stake by 8.1% in Q2 2026, buying an estimated $1.88M and bringing the position to 1,791,635 shares worth $32.2M. The position accounts for ﹤0.01% of the portfolio, ranked #1882.
Geode Capital Management first reported a position in IART in Q2 2013 and has held it in 53 quarters since. The position peaked at $67.4M in Q4 2021. 212 funds tracked by Wall St. Rank hold IART as of Q2 2026.
- Geode Capital Management held 1,791,635 shares of Integra LifeSciences worth $32.2M as of Q2 2026.
- Geode Capital Management bought 134,650 Integra LifeSciences shares in Q2 2026, an estimated $1.88M.
- Integra LifeSciences made up ﹤0.01% of Geode Capital Management's portfolio in Q2 2026, its #1882 holding.
- Geode Capital Management first reported a position in Integra LifeSciences in Q2 2013 and has held it in 53 quarters since.
- Geode Capital Management's Integra LifeSciences position peaked at $67.4M in Q4 2021.
- 212 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2026.
Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.